Community-acquired pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus in an HIV-2-infected patient

International Journal of STD and AIDS

Volumn 22, Issue 10, 2011, Pages 610-612

  Daneshvar, C ^a   Smith, N C ^a   Waghorn, D J ^a   Luzzi, G A ^a   Wathen, C G ^a  

^a WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

Community acquired pneumonia; HIV; HIV 2; PVL producing S. aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; LABORATORY TEST; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; FATAL OUTCOME; FEMALE; GAMBIA; HIV INFECTIONS; HIV-2; HUMANS; LEUKOCIDINS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCUS AUREUS;

EID: 80054773617     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009372     Document Type: Article

References (16)

1. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333:845-51
2. Cordero E, Pachon J, Rivero A, et al. Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med 2000;162:2063-68
3. Christensen D, Feldman C, Rossi P, et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis 2005;41:554-56
4. Norrgren H, Cardoso AN, da Silva ZJ, et al. Increased prevalence of HIV-2 infection in hospitalized patients with severe bacterial diseases in Guinea-Bissau. Scand J Infect Dis 1997;29:453-59
5. Rimland D, Navin TR, Lennox JL, et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002;16:85-95
6. Madeddu G, Porqueddu EM, Cambosu F, et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008;36:231-36
7. Onyemelukwe GC, Musa BO. CD4+ and CD8+ lymphocytes and clinical features of HIV seropositive Nigerians on presentation. Afr J Med Med Sci 2002;31:229-33
8. Melles DC, Pauw E, van den Boogaard L, et al. Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients. Microbes Infect 2008;10:151-58
9. Chetchotisakd P, Anunnatsiri S, Puapermpoonsiri S, et al. A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient. Southeast Asian J Trop Med Public Health 2007;38:690-94
10. Morgan M. Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia. BMJ 2005;331:793-94
11. Health Protection Agency. Guidance on the Diagnosis and Management of PVL-associated Staphylococcus aureus Infection (PVL-SA) in England. London: HPA, 2008: See: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH_087173 (last accessed 04 October 2011)
12. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-59
13. Morgan MS. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 2007;30:289-96
14. Stevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007;195:202-11
15. de Silva TI, Cotten M, Rowland-Jones SL. HIV-2: the forgotten AIDS virus. Trends Microbiol 2008;16:588-95
16. Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000;160:3286-93